Literature DB >> 33396603

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.

Ping Gong1,2, Yifan Wang2, Pengfei Zhang1, Zhaogang Yang2, Weiye Deng2, Zhihong Sun1,3, Mingming Yang2, Xuefeng Li2, Gongcheng Ma1, Guanjun Deng1, Shiyan Dong2, Lintao Cai1, Wen Jiang2.   

Abstract

Despite the advances in surface bioconjugation of synthetic nanoparticles for targeted drug delivery, simple biological functionalization is still insufficient to replicate complex intercellular interactions naturally. Therefore, these foreign nanoparticles are inevitably exposed to the immune system, which results in phagocytosis by the reticuloendothelial system and thus, loss of their biological significance. Immunocyte membranes play a key role in intercellular interactions, and can protect foreign nanomaterials as a natural barrier. Therefore, biomimetic nanotechnology based on cell membranes has developed rapidly in recent years. This paper summarizes the development of immunocyte membrane-coated nanoparticles in the immunotherapy of tumors. We will introduce several immunocyte membrane-coated nanocarriers and review the challenges to their large-scale preparation and application.

Entities:  

Keywords:  T-cell; biomimicry; cancer immunotherapy; dendritic cell; immunocyte membrane-coated nanoparticles; macrophage; natural killer

Year:  2020        PMID: 33396603     DOI: 10.3390/cancers13010077

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  10 in total

Review 1.  The Critical Role of RNA m6A Methylation in Gliomas: Targeting the Hallmarks of Cancer.

Authors:  Zhouhan Xu; Jun Jiang; Shun Wang
Journal:  Cell Mol Neurobiol       Date:  2022-09-15       Impact factor: 4.231

2.  "Pincer movement": Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles.

Authors:  Boyi Niu; Yixian Zhou; Kaixin Liao; Ting Wen; Sixian Lao; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2021-10-21       Impact factor: 14.903

3.  Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.

Authors:  Cheng Du; Xin Guan; Yao Liu; Zhuxuan Xu; Xiaowei Du; Baolei Li; Meiling Wang; Zhendong Zheng
Journal:  Cancer Chemother Pharmacol       Date:  2022-02-24       Impact factor: 3.288

4.  In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.

Authors:  Alessandra Romano; Nunziatina Laura Parrinello; Giuseppe Alberto Palumbo; Francesco Di Raimondo; Martina Barchitta; Rosy Manuele; Fabrizio Puglisi; Andrea Maugeri; Alessandro Barbato; Anna Maria Triolo; Cesarina Giallongo; Daniele Tibullo; Lucia La Ferla; Ciro Botta; Sergio Siragusa; Carmelo Iacobello; Arturo Montineri; Giovanni Li Volti; Antonella Agodi
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

Review 5.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

6.  Formulation and Characterization of Poly (Ethylene Glycol)-Coated Core-Shell Methionine Magnetic Nanoparticles as a Carrier for Naproxen Delivery: Growth Inhibition of Cancer Cells.

Authors:  Faten Eshrati Yeganeh; Amir Eshrati Yeganeh; Mohammad Yousefi; Bahareh Farasati Far; Iman Akbarzadeh; Dmitry Olegovich Bokov; Kaamran Raahemifar; Madjid Soltani
Journal:  Cancers (Basel)       Date:  2022-04-01       Impact factor: 6.639

Review 7.  Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy.

Authors:  Biao-Qi Chen; Yi Zhao; Yang Zhang; Yu-Jing Pan; Hong-Ying Xia; Ranjith Kumar Kankala; Shi-Bin Wang; Gang Liu; Ai-Zheng Chen
Journal:  Bioact Mater       Date:  2022-08-10

Review 8.  Cell membrane coated-nanoparticles for cancer immunotherapy.

Authors:  Yingping Zeng; Sufen Li; Shufen Zhang; Li Wang; Hong Yuan; Fuqiang Hu
Journal:  Acta Pharm Sin B       Date:  2022-02-28       Impact factor: 14.903

9.  Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy.

Authors:  Natacha Jugniot; Jeremy J Dahl; Ramasamy Paulmurugan
Journal:  J Exp Clin Cancer Res       Date:  2022-10-12

Review 10.  Biomimetic Nanostructure Platform for Cancer Diagnosis Based on Tumor Biomarkers.

Authors:  Xiping He; Yifan Ma; Haotian Xie; Gaofeng Rao; Zhaogang Yang; Jingjing Zhang; Zhong Feng
Journal:  Front Bioeng Biotechnol       Date:  2021-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.